Description of the urine test:

Bence-Jones proteins are “free light chains” (parts of antibodies) produced in excessive amounts by malignant plasma cells. Unlike normal antibodies, which are large and stay in the blood, these fragments are so small that they pass easily through the kidneys and enter the urine. Because they are often “invisible” to standard urine dipstick tests (which mainly detect albumin), a specific test for Bence-Jones protein is required to find them.

What Does the Test Represent?

• Goal: To detect the presence of monoclonal free light chains (Kappa or Lambda) in the urine.
• Main Application: Diagnosing and monitoring Multiple Myeloma, Waldenström’s macroglobulinemia, and light-chain amyloidosis.
• Method: Urine Immunofixation (the most accurate) or heat precipitation (an older, less common method).

Collection Recommendations (General)

• Timing: A 24-hour urine collection is the gold standard, as the secretion of these proteins can vary throughout the day.
• Procedure: Start the collection after the first morning void (discard it) and collect all subsequent urine for a full 24 hours.
• Material: Urine.
• Storage: The sample must be kept cool (refrigerated) during the entire collection period to prevent protein degradation.

Factors Influencing the Result

• Kidney Damage: These proteins are toxic to the kidneys. If they reach high levels, they can cause “Myeloma Kidney,” leading to a decrease in kidney function which can be seen in elevated creatinine levels.
• Sample Freshness: If the urine is left at room temperature, bacteria can grow and break down the Bence-Jones proteins, leading to a false-negative result.
• Type of Myeloma: About 15–20% of patients with multiple myeloma produce only Bence-Jones proteins (Light Chain Myeloma), making this test the only way to catch the disease in its early stages.

When to Take This Test?

• Recommendations: If you have unexplained bone pain (especially in the back or ribs), frequent infections, high calcium levels in the blood, or sudden kidney failure.
• Importance: Early detection of Bence-Jones protein can prevent irreversible kidney damage. Once treatment starts, the disappearance of this protein from the urine is a primary sign that the therapy is working.

Medical Interpretation

• Crucial Note: The presence of Bence-Jones protein is almost always a sign of a plasma cell disorder. Only a specialist can “fine-tune” the diagnosis by combining this with a bone marrow biopsy and imaging (like an MRI or PET scan).
• Positive Result: Indicates a monoclonal gammopathy, most commonly Multiple Myeloma.
• Negative Result: Does not completely rule out myeloma (some types do not shed light chains into urine), but it makes light-chain disease much less likely.

Possible Further Investigations

• Serum Free Light Chain (sFLC) Assay: A highly sensitive blood test that measures the ratio of Kappa to Lambda chains.
• Serum Protein Electrophoresis (SPEP): To look for a corresponding “M-spike” in the blood.
• Bone Marrow Biopsy: To count the percentage of plasma cells.
• Complete Blood Count (CBC): To check for anemia, which is common in these conditions.
• Consultation with a Hematologist.

When Does the Next Step Make Sense?

• If Bence-Jones protein is detected, the next step is an immediate referral to a hematologist-oncologist. They will likely order a bone marrow study and skeletal imaging to determine the extent of the disease and start protective treatment for the bones and kidneys.
• All clinical decisions must be made by a healthcare professional based on the definitive identification of the monoclonal protein.

👉 If necessary, you can discuss the analysis results with a specialist such as a hematologist (Doctors – TAMC).